Walleye Capital’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$772K Sell
91,064
-31,626
-26% -$210K ﹤0.01% 2347
2026
Q1
$669K Buy
+122,690
New +$688K ﹤0.01% 2430
2025
Q4
Sell
-228,259
Closed -$1.76M 5121
2025
Q3
$1.76M Buy
228,259
+207,469
+998% +$1.62M 0.01% 1666
2025
Q2
$181K Buy
20,790
+14,606
+236% +$106K ﹤0.01% 3437
2025
Q1
$49.2K Buy
6,184
+6,030
+3,916% +$61K ﹤0.01% 3846
2024
Q4
$1.4K Sell
154
-127
-45% -$1.23K ﹤0.01% 4687
2024
Q3
$2.58K Sell
281
-115,279
-100% -$954K ﹤0.01% 5064
2024
Q2
$1.13M Buy
115,560
+85,134
+280% +$1.04M ﹤0.01% 2712
2024
Q1
$459K Buy
+30,426
New +$552K ﹤0.01% 3269
2023
Q1
Sell
-2,531
Closed -$67.7K 4353
2022
Q4
$59.9K Buy
+2,531
New +$68.2K ﹤0.01% 2488
2022
Q2
Sell
-15,896
Closed -$1.15M 2714
2022
Q1
$1.15M Buy
15,896
+8,731
+122% +$629K 0.03% 577
2021
Q4
$658K Buy
+7,165
New +$856K 0.02% 813
2020
Q2
Sell
-1,736
Closed -$270K 953
2020
Q1
$270K Buy
1,736
+1,506
+655% +$175K 0.06% 367
2019
Q4
$19K Buy
+230
New +$17.5K ﹤0.01% 1610

Other funds holding TDOC

Walleye Capital's TDOC Position: Q2 2026 in Review

Walleye Capital reduced its Teladoc Health (TDOC) stake by 26% in Q2 2026, selling an estimated $210K and leaving 91,064 shares worth $772K. The position accounts for ﹤0.01% of the portfolio, ranked #2347.

Walleye Capital first reported a position in TDOC in Q4 2019 and has held it in 14 quarters since. The position peaked at $1.76M in Q3 2025. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Walleye Capital held 91,064 shares of Teladoc Health worth $772K as of Q2 2026.
  • Walleye Capital sold 31,626 Teladoc Health shares in Q2 2026, an estimated $210K.
  • Teladoc Health made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #2347 holding.
  • Walleye Capital first reported a position in Teladoc Health in Q4 2019 and has held it in 14 quarters since.
  • Walleye Capital's Teladoc Health position peaked at $1.76M in Q3 2025.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.